Company description
Gene therapy is a promising approach, but it requires improving gene transduction in clinical trials. The vaccinia virus (VACV or VV) is a large and complex enveloped virus which is a member of the Poxviridae family, widely used for high-level cytoplasmatic expression of transgenes. The vaccinia virus has been successfully used as a vaccine to eradicate smallpox. Besides, it also serves as a tool to transfer genes to biological tissues. Creative Biolabs provides highly attenuated, host-restricted, non- or poorly replicating vaccinia virus strains covering multiple gene delivery demands in gene therapy all over the world.
